Mesothelioma.com Resources for Patients and their Families

Mesothelioma Doctors

Raphael Bueno, M.D.

Dr. Bueno
Boston, MA

Expert

Dr. Raphael Bueno

Chief, Division of Thoracic Surgery; Co-Director, The Lung Center

Brigham and Women's Hospital

75 Francis Street
Boston, MA 02115
(617) 732-8148

Harvard Medical School - 1985

Brigham and Women's Hospital - 1993

Massachusetts General Hospital - 1995

Overview/Educational Background

Dr. Raphael Bueno is the Chief, Division of Thoracic Surgery and Vice Chair of Surgery for Cancer and Translational Research at Boston’s Brigham and Women’s Hospital, a teaching affiliate of the Harvard University College of Medicine where Dr. Bueno also serves as Professor of Surgery. As a 1985 graduate of Harvard Medical School, Dr. Bueno completed a residency program at Brigham and Women’s Hospital and a fellowship in Thoracic Surgery at the Massachusetts General Hospital.

Board certified in 1993, Dr. Bueno spent much of his early career teaching at the Harvard Medical College throughout the 1990’s. Much of Dr. Bueno’s more recent focus has been treating patients of malignant mesothelioma and lung cancer at various stages. Dr. Bueno has studied extensively the behavior of all types of mesothelioma (including peritoneal mesothelioma and pericardial mesothelioma) at a cellular level with hopes of integrating his growing knowledge of cell-level behavior into more aggressive and effective mesothelioma treatment regimens.

Professional Highlights/Clinical Research

Dr. Bueno’s current research initiatives include the investigation of new targets for lung cancer and mesothelioma therapies, as well as the development of tests aimed at detecting cancer and identifying the prognosis of patients with thoracic malignancies following surgery. He is the lead investigator of several ongoing clinical trials, one of which is examining biomarker responses in tumor tissue in surgical patients with malignant pleural mesothelioma.

Dr. Bueno serves today as Program and Research Director of the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital/Harvard Medical School—the largest program of its kind in the world that was founded with the mission of offering patients with malignant pleural mesothelioma the most innovative and advanced treatment regimens available. Much of Dr. Bueno’s research has been published in national medical journals, including the Journal of Thoracic Cardiovascular Surgery. Among the topics explored in his publications are the molecular pathways and therapeutic targets in lung cancer, chemotherapeutic drug resistance in primary malignant pleural mesothelioma, and gene expression ratio testing targeting the classification of normal lung vs. lung tumors. U.S. News and World Report has recently lauded Dr. Bueno’s research in their physician rankings. Patients with malignant mesothelioma are urged to explore if Dr. Bueno’s expertise in the field may be beneficial to them.

Publications

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Share
Tweet
Share
Sources

Brigham and Women’s Hospital
http://www.chestsurg.org/about/staff/raphael-bueno.aspx
http://physiciandirectory.brighamandwomens.org/Details/1303
http://www.brighamandwomens.org/research/centers/cancer/Researchers/Bueno.aspx

International Mesothelioma Program
http://impmeso.org/the-imp-program/imp-leadership/raphael-bueno-md/

Clinical Trials.gov—A service of the U.S. National Institutes of Health
http://clinicaltrials.gov/ct2/results?term=raphael+bueno&Search=Search

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To: